The Technion’s story has been intertwined with Israel’s for more than a century, from laying the foundations for a new nation to shaping its future.
Step inside Israeli innovation at the David and Janet Polak Visitors Center. Experience our 360° immersive movie and tech exhibition. Open to individuals and groups.
Learn More
Iris Grossman always thought she’d become a neurologist, but as a Ph.D. candidate at the Technion, she worked closely with Teva Pharmaceuticals (opens in a new tab) and fell in love with personalized medicine. Her expertise in science and analytics has opened doors to high-level positions and consultancies at Teva, GlaxoSmithKline (opens in a new tab), Eli Lilly (opens in a new tab), and Takeda (opens in a new tab), as well as chief scientific officer roles at CAMP4 Therapeutics and Amide Technologies. Currently, she is chief strategy officer at the Israeli-British Eleven Therapeutics.
Dr. Grossman, a modern Orthodox mother of four who currently resides in Boston, is part of a multigenerational Technion legacy as her mother, father, brother, and husband, Aharon Grossman ’04, are all alumni. “It’s a joke in the family that our children can major in whatever they want, as long as they go to the Technion,” she said.
“It is completely awe-inspiring to see the impact Technion alumni have made in every aspect of our lives,” Dr. Grossman said. “There are many wonderful universities here, but they are not as innovative
or interdisciplinary as the Technion. It is our responsibility as alumni to nurture and invest in that creative approach.”
Pictured Above / Iris Grossman with her children (from l to r) Carmel, Eden, Harel, and Avri, and husband, Aharon